4606539 发表于 2018-8-17 16:30:03

2018曲美他嗪在糖尿病合并冠心病治疗中的效果研究

  [摘要] 目的 探讨曲美他嗪治疗糖尿病合并冠心病的效果。方法 选取该院2015年12月―2016年12月收治的糖尿病合并冠心病患者94例,随机分为两组各47例,对照组给予常规治疗,观察组在对照组基础上给予曲美他嗪。结果 观察组总有效率为91.49%,明显优于对照组76.59%(P0.05),观察组心绞痛发作次数(3.1±0.1)次/周,持续时间(3.7±0.5)min均明显优于对照组(P http://
  [关键词] 曲美他嗪;糖尿病;冠心病;效果
  [中图分类号] R587.1 [文献标识码] A [文章编号] 1672-4062(2017)06(a)-0081-02
   Objective This paper tries to investigate the effect of trimetazidine in the treatment of diabetes mellitus complicated with coronary heart disease. Methods 94 patients with diabetes mellitus complicated with coronary heart disease from December 2015 to December 2016 were selected and randomly divided into two groups, with 47 cases in each group. The control group received conventional treatment; the observation group was given trimetazidine on the basis of the control group. Results The total effective rate of the observation group was 91.49%, significantly better than that of the control group 76.59%(P0.05), the number of angina attacks in the observation group was (3.1±0.1)times/week, and the duration was (3.7±0.5)minutes, significantly better than those in the control group (P统计学意义(P>0.05)。
  1.2 治疗方法
  对照组给予常规治疗,包括肠溶阿司匹林、他汀类、硝酸酯类、血管紧张素转换酶抑制剂、强心剂等,进行3个月治疗;观察组在对照组的基础上给予曲美他嗪片(20 mg/片,国药准字H20055465)20 mg口服,3次/d,连服3个月。
页: [1]
查看完整版本: 2018曲美他嗪在糖尿病合并冠心病治疗中的效果研究